Honest reviews of 89+ online health providers across GLP-1 weight loss, TRT, ED, hair loss, women's health, longevity, peptides, and primary care. Compare pricing, clinical oversight, and real patient experiences.
Mean body-weight change was −14.9% with semaglutide and −2.4% with placebo.
1,961 adults with obesity or overweight plus a weight-related condition, without diabetes; 68 weeks. Read the linked peer-reviewed source for the full methodology, findings, and limitations.
Wilding et al., NEJM 2021 · STEP 1